| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President And CEO +1 more
3 companies
Enright William is a Chief Executive Officer at Barinthus Biotherapeutics plc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | BFRG Bullfrog Ai Holdings, Inc. | Director | Buy | 5,000 | $4.05 | $20,250.00 | New | -24.7% | -29.1% | |
| Mar 27, 2023 | BRNS Barinthus Biotherapeutics Plc. | Chief Executive Officer | Sell | 15,000 | $2.42 | $36,298.50 | -2.0% | -8.1% | -2.8% | |
| May 25, 2018 | ALT Altimmune, Inc. | President And CEO | Buy | 1,300 | $0.51 | $659.88 | +0.4% | - | - |